We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-3.2%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$745B
AUM Growth
+$33.9B
Cap. Flow
-$10.6B
Cap. Flow %
-1.43%
Top 10 Hldgs %
31.69%
Holding
14,193
New
1,741
Increased
5,205
Reduced
5,319
Closed
1,559

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$2.17B
2
AMZN icon
Amazon
AMZN
+$1.98B
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.79B
4
NVDA icon
NVIDIA
NVDA
+$1.18B
5
WFC icon
Wells Fargo
WFC
+$827M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.63%
2 Technology 1.89%
3 Consumer Discretionary 1.29%
4 Communication Services 0.93%
5 Healthcare 0.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTMI icon
10126
TTM Technologies
TTMI
$12.5B
$358K ﹤0.01%
+28,496
New +$392K
GPX
10127
CALL
DELISTED
GP Strategies Corp.
GPX
$358K ﹤0.01%
+17,300
New +$343K
CPSH icon
10128
PUT
CPS Technologies
CPSH
$73.7M
$357K ﹤0.01%
71,800
+18,000
+33% +$110K
MEI icon
10129
CALL
Methode Electronics
MEI
$646M
$357K ﹤0.01%
8,500
-5,600
-40% -$257K
ORIC icon
10130
Oric Pharmaceuticals
ORIC
$1.37B
$357K ﹤0.01%
17,066
-4,978
-23% -$101K
PCOR icon
10131
PUT
Procore
PCOR
$9.68B
$357K ﹤0.01%
4,000
+1,000
+33% +$94.3K
PTEN icon
10132
CALL
Patterson-UTI
PTEN
$4.74B
$357K ﹤0.01%
39,700
-56,700
-59% -$459K
ENZ
10133
PUT
DELISTED
Enzo Biochem, Inc.
ENZ
$357K ﹤0.01%
100,800
+66,300
+192% +$221K
TSOC
10134
DELISTED
Innovator Triple Stacker ETF - October
TSOC
$357K ﹤0.01%
11,689
-11,575
-50% -$353K
GTPBU
10135
DELISTED
Gores Technology Partners II, Inc. Units
GTPBU
$357K ﹤0.01%
35,984
BSN
10136
PUT
DELISTED
Broadstone Acquisition Corp.
BSN
$357K ﹤0.01%
+35,900
New +$355K
CRMD icon
10137
CALL
CorMedix
CRMD
$647M
$356K ﹤0.01%
76,500
-44,800
-37% -$261K
KEN icon
10138
Kenon Holdings
KEN
$3.5B
$356K ﹤0.01%
+8,600
New +$321K
USLB
10139
DELISTED
Invesco Russell 1000 Low Beta Equal Weight ETF
USLB
$356K ﹤0.01%
9,138
-3,692
-29% -$148K
ACTG icon
10140
Acacia Research
ACTG
$436M
$355K ﹤0.01%
52,356
+14,157
+37% +$86.7K
CKPT
10141
CALL
DELISTED
Checkpoint Therapeutics
CKPT
$355K ﹤0.01%
10,750
+2,410
+29% +$71.2K
KALA icon
10142
KALA BIO
KALA
$13.3M
$355K ﹤0.01%
54
-24
-31% -$207K
LCNB icon
10143
PUT
LCNB Corp
LCNB
$277M
$355K ﹤0.01%
+20,100
New +$343K
SITC icon
10144
SITE Centers
SITC
$157M
$355K ﹤0.01%
29,489
-11,128
-27% -$135K
TDC icon
10145
Teradata
TDC
$2.68B
$355K ﹤0.01%
+6,185
New +$319K
XDAP
10146
DELISTED
Innovator U.S. Equity Accelerated ETF - April
XDAP
$355K ﹤0.01%
13,025
-812
-6% -$22.4K
NGM
10147
CALL
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$355K ﹤0.01%
+16,900
New +$372K
ATXS
10148
PUT
DELISTED
Astria Therapeutics
ATXS
$354K ﹤0.01%
40,000
+36,233
+962% +$347K
GAIA icon
10149
PUT
Gaia
GAIA
$39.4M
$354K ﹤0.01%
37,300
+600
+2% +$6.32K
KTB icon
10150
Kontoor Brands
KTB
$4.21B
$354K ﹤0.01%
7,093
-49,487
-87% -$2.74M

Similar funds

Jeff Yass's Q3 2021 Portfolio in Review

As of Q3 2021, Jeff Yass held 14,193 positions worth $745B, up 4.8% from $712B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q3 2021 filing shows 1,741 new, 5,205 increased, 5,319 reduced and 1,559 closed positions. Its largest new stake was InMode: 613,660 shares worth $48.9M. The largest sale was Walt Disney, an estimated $2.17B.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 91% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q3 2021 buy was InMode: 613,660 shares worth $48.9M.
  • Jeff Yass added most to Zoom in Q3 2021, an estimated $834M increase.
  • Jeff Yass's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $2.17B.
  • Jeff Yass fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $103M.
  • Jeff Yass's ten largest holdings make up 32% of its $745B portfolio in Q3 2021.
  • Jeff Yass opened 1,741 new positions and closed 1,559 in Q3 2021.
  • Jeff Yass's portfolio value rose 4.8% quarter-over-quarter to $745B.

Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.